Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theratope vaccine in metastatic breast cancer
NCT00003638Phase 3Completed
- Sponsor
- Oncothyreon Inc.
- Start
- Jan 1999
- Primary completion
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes, Split/Subunit Vaccines, Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Theratope STn-KLH vaccine in breast cancer, sponsored by Oncothyreon Inc.. Started Jan 1999; status: completed.
02
Drugs
Theratope STn-KLH vaccine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003638.